Top Markets
Coin of the day
Zelluna ASA Zelluna ASA

Zelluna ASA

ZLNA
Rank in Stocks #23821
Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes... Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes in the creation of T-cell receptor (TCR) cellular immunotherapy treatments aimed at combating solid tumors.
Share Price
$2.34
Last synced: 2026-08-21
Market Cap
$68.75M
Change (1 day)
1.36%
Change (1 year)
67.90%
Country
NO
Trade Zelluna ASA (ZLNA)

Category

Revenue for Zelluna ASA (ZLNA)
Revenue in Aug 2026 TTM: 0
According to Zelluna ASA latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zelluna ASA from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$12.62B -
US
$6.02B -
NL
$2.23B -
US
$15.74B -
AU
- -
CH